We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novavax: Early Study Indicates Its Vaccine Effective Vs. RSV

News   Aug 12, 2015

 
Novavax: Early Study Indicates Its Vaccine Effective Vs. RSV
 
 
Advertisement
 

RELATED ARTICLES

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

Neanderthal Protein May Reduce the Severity of COVID-19

News

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes.

READ MORE

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE